Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer

Author： Zeliadt Steven B.   Penson David F.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.4, 2007-01, pp. : 309-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metastatic Colorectal Cancer: Current Systemic Treatment Options

By Board Ruth E.   Valle Juan W.  

Drugs, Vol. 67, Iss. 13, 2007-01 ,pp. : 1851-1867

Adis International

Access to resources Recommend Favorite

Options for prostate cancer after curative treatment failure

By  

Inpharma, Vol. 1, Iss. 1276, 2001-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Treatment Options in Hormone-Refractory Prostate Cancer: Current and Future Approaches

By Harris K.A.   Reese D.M.  

Drugs, Vol. 61, Iss. 15, 2001-01 ,pp. : 2177-2192

Adis International

Access to resources Recommend Favorite

Adjuvant Therapy in Prostate Cancer: Patient Identification and Treatment Options

By Syed S.   Tolcher A.   Troyer D.   Furman J.   Leach R.   Thompson I.M.  

UroOncology, Vol. 4, Iss. 3-4, 2004-09 ,pp. : 119-126

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Therapeutic options for metastatic breast cancer

By Morris Patrick G   McArthur Heather L   Hudis Clifford A  

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 6, 2009-04 ,pp. : 967-981

Informa Healthcare

Access to resources Recommend Favorite